Using Epidemiology Data in HTA Submissions: A Practical Framework
How pharmaceutical companies can structure robust epidemiology evidence packages for health technology assessment bodies in the UK, Germany, France, and beyond.
Read MoreEpivantage specializes in the development of rigorously researched and detailed epidemiological forecast models that are fit for purpose in the age of genetic medicine, targeted treatments and niche drug labels. These models are available on a custom basis or as downloadable files from our Model Library.
Learn More About UsExplore Structured Epidemiology-Focused Products Designed For Strategic Planning And Epidemiology Analysis.
20-Year Patient Population Forecasts With Downloadable Excel Datasets, Dashboards, And Full Methodology Documentation.
Learn MoreStructured Publications On Disease Burden, Treatment Pathways, Competitive Landscape, And Market Opportunity Across Therapeutic Areas.
Learn MoreBespoke Epidemiology Projects Tailored To Your Specific Strategic Questions — From HTA Submissions To Investor Presentations.
Learn MoreDiscover how epidemiology insights and epidemiology-focused support strategic decision-making across healthcare organizations.
Epivantage Combines Research-Driven Methodologies, Epidemiology-Focused Expertise, And Scalable Digital Infrastructure To Help Pharmaceutical And Healthcare Organizations.
Every Forecast Model, Disease Analysis, And Healthcare Insight Is Developed Using Structured Research Methodologies, Validated Epidemiological Approaches, And Analytical Rigor To Ensure Dependable, Decision-Ready Intelligence For Healthcare And Pharmaceutical Stakeholders.
Purpose-Built Epidemiology-Focused Solutions Designed Specifically For Pharmaceutical Companies, Consulting Firms, And Healthcare Research Organizations.
Protected Access Infrastructure Ensures Authorized Users Can Securely View And Download Premium Reports, Forecast Models, And Restricted Research Resources.
How pharmaceutical companies can structure robust epidemiology evidence packages for health technology assessment bodies in the UK, Germany, France, and beyond.
Read MoreKey epidemiological shifts in the oncology landscape — including improving survival rates, expanding screening programmes, and changing incidence patterns — and their implications for pipeline strategy.
Read MoreA comprehensive guide to the foundational principles of age-period-cohort modelling and how Epivantage applies validated epidemiological frameworks to generate decision-ready forecast models. In this article: Forecasting methodology principles
Read More